Donor explorer

GSE243013_NSCLC_anti_PD1

Dataset-level donor/sample index migrated from ImmuneAging into LACA. Open a donor ID to inspect de-identified metadata, source notes, and UMAP preview status.

Browse donors Back to atlas

CIMA_PBMC_Science_2025 COVID19_PBMC Neutrophil_LiverCancer_Nature_2022 SCAR244 HCC_GSE140228_Cell_2019 Thymus_PBMC_NatureAging_2025 CancerSCEM 2.0 LGH_Immunity Fetus_PBMC_Cell_2025 GSE243013_NSCLC_anti_PD1 GSE279452_Sepsis_PBMC GSE134355_Human_Cell_Landscape_HCL GSE316337_Type1_Diabetes_PBMC GSE254249_Rectal_Cancer_TNT GSE206785_Gastric_Cancer_TME GSE182159_HBV_Liver_Blood_Immune GSE189955_HGSC_Multiomics GSE149938_Human_Blood_Cell_Atlas GSE207422_NSCLC_PD1_Chemo GSE221521 GSE255685 GSE182409 Han Chinese serum proteome pQTL / GNHS + WEBIRTH CRC plasma proteomics, Zhejiang discovery cohort RA serum proteomics, Guangzhou MTBLS13155 MTBLS352 MTBLS11996 MTBLS12968 MTBLS12820 MTBLS13501 MTBLS9664 MTBLS5568 Bian_PBMC_NI_2025 LGH_X_Age

PopulationChinese NSCLC cohort

ModalityscRNA-seq + TCR-seq

DataGEO processed files mirrored on pandora002; Tracking donor IDs generated; UMA...

Donor Table

243 rows in this dataset; 50 rows per page.

						Details
HIA-GSE243013-D0001	P1	62 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0002	P2	66 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0003	P3	64 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0004	P4	64 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0005	P5	56 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0006	P6	56 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0007	P9	64 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0008	P10	50 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0009	P16	72 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0010	P18	52 years	Female	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0011	P20	49 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0012	P22	68 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0013	P23	68 years	Female	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0014	P24	55 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0015	P26	54 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0016	P29	70 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0017	P31	58 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0018	P32	69 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0019	P33	63 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0020	P34	64 years	Female	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0021	P35	57 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0022	P36	56 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0023	P39	67 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0024	P43	46 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0025	P44	68 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0026	P45	64 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0027	P46	55 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0028	P47	76 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0029	P49	72 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0030	P52	34 years	Female	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0031	P53	64 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0032	P57	57 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0033	P58	50 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0034	P59	58 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0035	P62	68 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0036	P63	63 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0037	P64	64 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0038	P66	66 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0039	P67	65 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0040	P68	53 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0041	P69	74 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0042	P70	71 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0043	P71	50 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0044	P73	54 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0045	P74	66 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0046	P84	60 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0047	P90	67 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0048	P92	53 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0049	P93	74 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0050	P94	74 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0051	P96	67 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0052	P97	71 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0053	P102	74 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0054	P103	67 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0055	P105	65 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0056	P106	57 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0057	P107	78 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0058	P111	55 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0059	P113	72 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0060	P114	65 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0061	P115	60 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0062	P118	46 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0063	P119	64 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0064	P120	64 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0065	P121	59 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0066	P122	62 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0067	P124	64 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0068	P125	67 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0069	P127	58 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0070	P130	59 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0071	P131	61 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0072	P137	63 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0073	P142	61 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0074	P146	67 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0075	P150	72 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0076	P156	63 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0077	P158	59 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0078	P159	59 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0079	P160	36 years	Female	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0080	P161	59 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0081	P164	49 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0082	P166	52 years	Female	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0083	P168	73 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0084	P172	49 years	Female	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0085	P174	64 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0086	P179	66 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0087	P180	63 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0088	P181	52 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0089	P182	55 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0090	P184	56 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0091	P185	58 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0092	P189	61 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0093	P190	51 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0094	P192	73 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0095	P199	54 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0096	P200	51 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0097	P201	56 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0098	P204	50 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0099	P205	62 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0100	P206	64 years	Female	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0101	P207	63 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0102	P209	59 years	Female	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0103	P213	67 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0104	P218	64 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0105	P221	55 years	Female	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0106	P223	66 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0107	P224	46 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0108	P226	69 years	Female	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0109	P227	63 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0110	P233	71 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0111	P234	64 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0112	P235	63 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0113	P243	62 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0114	P247	68 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0115	P248	65 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0116	P249	71 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0117	P257	69 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0118	P258	57 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0119	P259	59 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0120	P261	51 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0121	P264	53 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0122	P265	67 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0123	P266	64 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0124	P267	69 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0125	P268	69 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0126	P270	55 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0127	P271	58 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0128	P273	67 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0129	P276	67 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0130	P277	71 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0131	P278	73 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0132	P279	48 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0133	P280	67 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0134	P281	72 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0135	P282	67 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0136	P285	64 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0137	P286	61 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0138	P287	66 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0139	P288	66 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0140	P289	59 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0141	P290	58 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0142	P291	57 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0143	P292	42 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0144	P293	59 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0145	P296	62 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0146	P297	46 years	Female	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0147	P298	64 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0148	P303	65 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0149	P304	67 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0150	P309	54 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0151	P312	55 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0152	P321	67 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0153	P322	68 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0154	P323	64 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0155	P325	59 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0156	P328	58 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0157	P329	65 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0158	P334	57 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0159	P337	72 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0160	P339	62 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0161	P340	55 years	Female	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0162	P346	75 years	Female	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0163	P347	62 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0164	P349	64 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0165	P355	52 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0166	P365	65 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0167	P367	67 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0168	P368	68 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0169	P371	57 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0170	P372	60 years	Female	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0171	P377	72 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0172	P380	59 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0173	P382	51 years	Female	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0174	P387	64 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0175	P389	58 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0176	P390	43 years	Female	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0177	P391	50 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0178	P394	67 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0179	P395	62 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0180	P399	58 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0181	P402	54 years	Female	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0182	P403	52 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0183	P404	59 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0184	P405	62 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0185	P407	70 years	Female	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0186	P412	67 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0187	P414	63 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0188	P416	53 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0189	P417	56 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0190	P418	64 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0191	P420	68 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0192	P423	59 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0193	P427	59 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0194	P428	73 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0195	P432	71 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0196	P433	74 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0197	P435	64 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0198	P445	59 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0199	P453	52 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0200	P454	54 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0201	P457	72 years	Female	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0202	P459	53 years	Female	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0203	P462	64 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0204	P463	68 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0205	P464	57 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0206	P467	63 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0207	P469	65 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0208	P470	66 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0209	P471	73 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0210	P472	61 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0211	P473	45 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0212	P477	69 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0213	P481	71 years	Female	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0214	P482	59 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0215	P483	68 years	Female	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0216	P485	72 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0217	P486	65 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0218	P488	72 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0219	P490	55 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0220	P491	62 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0221	P494	62 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0222	P495	65 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0223	P496	69 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0224	P498	63 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0225	P502	56 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0226	P509	49 years	Female	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0227	P510	56 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0228	P511	65 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0229	P520	49 years	Female	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0230	P523	70 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0231	P524	69 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0232	P525	54 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0233	P527	65 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0234	P528	64 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0235	P533	56 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0236	P540	73 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0237	P550	64 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0238	P567	69 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0239	P574	55 years	Female	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0240	P579	55 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0241	P587	58 years	Female	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0242	P592	44 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene
HIA-GSE243013-D0243	P595	64 years	Male	NSCLC anti-PD-1 post-neoadjuvant tumor samples	Tumor immune microenvironment	UMAP + Gene